LAMICTAL CD vs XCOPRI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Possible drug interaction. LAMICTAL CD and XCOPRI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LAMICTAL CD	XCOPRI
Rating	72/100	New
Pharmacy pays	~$4.43 /30	—
Type	RX	RX
Active ingredient	LAMOTRIGINE	CENOBAMATE
Manufacturer	Glaxosmithkline	Sk Life
Dosage forms	Tablet	Tablet
Drug class	Anti-Epileptic Agent	—
Boxed warning	Boxed warning	None
Half-life	about 25 to 33 hours in healthy adults taking no other medications — the label reports a mean elimination half-life of 32.8 hours after a single dose (individual range 14 to 103 hours) and 25.4 hours with repeat dosing (range 11.6 to 61.6 hours), since lamotrigine induces its own metabolism	—
Treats	Bipolar Disorder, Partial Epilepsies, Seizures	Partial Epilepsies

lamictal cd xcopri

Rating

72/100

New

Pharmacy pays

~$4.43 /30

—

Type

Active ingredient

LAMOTRIGINE

CENOBAMATE

Manufacturer

Glaxosmithkline

Sk Life

Dosage forms

Tablet

Drug class

Anti-Epileptic Agent

—

Boxed warning

None

Half-life

about 25 to 33 hours in healthy adults taking no other medications — the label reports a mean elimination half-life of 32.8 hours after a single dose (individual range 14 to 103 hours) and 25.4 hours with repeat dosing (range 11.6 to 61.6 hours), since lamotrigine induces its own metabolism

—

Treats

Bipolar Disorder, Partial Epilepsies, Seizures

Partial Epilepsies

Frequently asked questions

What is the difference between Lamictal Cd and Xcopri?

Lamictal Cd contains Lamotrigine, while Xcopri contains Cenobamate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.